Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by bazooka73on Jul 26, 2017 2:38am
104 Views
Post# 26509597

RE:The Chart looks bad, needs to hold .14 support...... again

RE:The Chart looks bad, needs to hold .14 support...... again
hcdtrading wrote: The chart is looking terrible again. Last time I pointed this out and people cried and said I was a basher, I tried to point out to the simpletons that I am just being truthful and will comment when a chart looks good or bad.  Right now SBM looks bad so it needs to keep support at .14 or it will possibly see that .11 price that our friend keeps pitching us on.  Last time support held and the stock rebounded to .17, so we will see, but it does look really bad and I do see it drifting lower. 



Good charts base on statistics and they themself base on data (= transactions and pricing/day) So the larger the amount of data, the better statistcs you get and following that logic, the better gets your chart. Now question: How big, do you think, is the amount of data that your Sirona chart bases on? My honest estimation: It's at the very most a flyspeck...
Bullboard Posts